ストックスクリーナーアプリを入手
16.34
9.62%
-1.74
アフターアワーズ：
16.35
0.01
+0.06%
前日終値:
$18.08
開ける：
$18.14
24時間の取引高:
306.63K
Relative Volume:
4.88
時価総額：
$146.19M
収益：
$101.90M
当期純損益:
$-6.41M
株価収益率:
-3.7625
EPS:
-4.3429
ネットキャッシュフロー:
$-889.00K
1週間 パフォーマンス:
-12.43%
1か月 パフォーマンス:
-17.89%
6か月 パフォーマンス:
-47.70%
1年 パフォーマンス:
-47.63%
1日の値動き範囲:
$16.05
$18.32
1週間の範囲:
$16.05
$19.37
52週間の値動き範囲:
$16.05
$35.95
Sanara Medtech Inc Stock (SMTI) Company Profile
Compare SMTI vs ISRG, BDX, ALC, MDLN, RMD
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
SMTI
Sanara Medtech Inc
|
16.34 | 161.76M | 101.90M | -6.41M | -889.00K | -4.3429 |
ISRG
Intuitive Surgical Inc
|
469.98 | 167.61B | 10.06B | 2.88B | 2.49B | 7.876 |
BDX
Becton Dickinson Co
|
158.27 | 44.35B | 21.92B | 1.76B | 2.63B | 6.1223 |
ALC
Alcon Inc
|
75.26 | 36.19B | 10.40B | 980.00M | 1.61B | 1.9749 |
MDLN
Medline Inc
|
42.67 | 34.11B | 28.43B | 1.16B | 1.26B | 1.4457 |
RMD
Resmed Inc
|
226.31 | 33.24B | 5.40B | 1.49B | 1.78B | 10.12 |
Sanara Medtech Inc Stock (SMTI) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-03-26 | 繰り返されました | H.C. Wainwright | Buy |
| 2024-12-23 | 開始されました | H.C. Wainwright | Buy |
| 2022-05-20 | 再開されました | Cantor Fitzgerald | Overweight |
| 2021-06-30 | 開始されました | Cantor Fitzgerald | Overweight |
Sanara Medtech Inc (SMTI) 最新ニュース
Retail Trends: Can Sanara MedTech Inc maintain sales growth2026 Technical Patterns & AI Forecasted Entry and Exit Points - baoquankhu1.vn
Sanara MedTech Hits 52-Week Low of $17.54 Amidst Market Struggles - Markets Mojo
Sanara MedTech shares rise more than 3% despite fourth-quarter earnings miss - MSN
Sanara MedTech (SMTI) to Release Quarterly Earnings on Wednesday - Defense World
Sanara MedTech Inc. 2025 Business Overview: Surgical Product Focus, Innovation Strategy, and Regulatory Compliance - Minichart
Sanara MedTech Inc. (SMTI) Q4 earnings miss estimates - MSN
Sanara MedTech Inc (SMTI) Q4 2025 Earnings Call Highlights: Record Revenue and Strategic Growth ... By GuruFocus - Investing.com Canada
Sanara MedTech (NASDAQ: SMTI) ends THP unit, doubles down on surgery - Stock Titan
Sanara MedTech Inc (SMTI) Q4 2025 Earnings Call Highlights: Reco - GuruFocus
Targets Report: Can Sanara MedTech Inc deliver consistent dividends2026 Market Sentiment & Fast Entry High Yield Stock Tips - baoquankhu1.vn
Sanara MedTech Reports Strong 2025 Financial Results With 19% Revenue Growth, Reaffirms 2026 Guidance - Minichart
Sanara MedTech Inc. (SMTI) Q4 and Full Year 2025 Earnings: Revenue Hits $103.1 Million With 19% Growth - Bayelsa Watch
Sanara MedTech Q4 2025 Earnings Call Transcript - MarketBeat
Sanara Medtech earnings missed by $0.52, revenue fell short of estimates - Investing.com Canada
Sanara MedTech Inc. (SMTI) Q4 Earnings: Misses on EPS, Revenue Recap - AlphaStreet
Sanara MedTech Q4 Earnings Call Highlights - Yahoo Finance
Earnings call transcript: Sanara MedTech Q4 2025 misses EPS forecast, stock drops - Investing.com
Sanara MedTech Inc. (SMTI) Misses Q4 EPS Estimates by 215.9% - AlphaStreet
Sanara MedTech Inc. (SMTI) Q4 Earnings Miss Estimates - Yahoo Finance
Sanara Medtech Inc. Reaffirms Revenue Guidance for the Full Year Ending December 31, 2026 - marketscreener.com
Sanara MedTech stock rises over 3% despite fourth quarter miss By Investing.com - Investing.com India
Sanara MedTech Inc. Reports Fourth Quarter (Unaudited) and Full Year 2025 Financial Results; Reaffirmed Full Year 2026 Financial Guidance - The Manila Times
Sanara MedTech reports FY2025 revenue $103.1M, Q4 revenue $27.5M and Adjusted EBITDA $17.0M - TradingView
Sanara MedTech posts higher Q4 revenue, reaffirms guidance - TradingView
Sanara MedTech Inc. Reports Fourth Quarter (Unaudited) and - GlobeNewswire
Sanara MedTech Inc. (SMTI) Q4 Results Fall Short of Projections - Bitget
Sanara MedTech (SMTI) CEO receives 25,430-share restricted stock grant vesting through 2029 - Stock Titan
Sanara MedTech (SMTI) grants restricted stock to controller vesting through 2029 - Stock Titan
Sanara MedTech (SMTI) awards COO 13,956 restricted shares - Stock Titan
Sanara MedTech (SMTI) CFO awarded 12,687 restricted shares vesting 2027-2029 - Stock Titan
What To Expect From Sanara MedTech Inc (SMTI) Q4 2025 Earnings - GuruFocus
Can Sanara MedTech Inc grow without external fundingDay Trade & AI Enhanced Market Trend Forecasts - baoquankhu1.vn
Price-Driven Insight from (SMTI) for Rule-Based Strategy - Stock Traders Daily
Is Sanara MedTech Inc undervalued by DCF analysisWeekly Trend Recap & Weekly Momentum Stock Picks - baoquankhu1.vn
Sanara MedTech (NASDAQ:SMTI) Trading Up 0.8%Here's What Happened - MarketBeat
Aug Selloffs: Can Sanara MedTech Inc maintain sales growth2026 Earnings Surprises & High Accuracy Trade Alerts - baoquankhu1.vn
Sanara MedTech Inc. Announces Publication of Peer-Reviewed Study Evaluating the Economic and Clinical Value of CellerateRX® Surgical Powder in the Management of Spine Surgery Wounds - Orthopedics This Week
Sanara MedTech (SMTI) upgraded to strong buy: Here's what you should know - MSN
Sanara MedTech study shows cost savings with CellerateRX powder By Investing.com - Investing.com India
Sanara MedTech Inc. Announces Publication of Peer-Reviewed - GlobeNewswire
Sanara MedTech study shows cost savings with CellerateRX powder - Investing.com
Sanara MedTech (SMTI) Study Highlights Cost-Effectiveness of Cel - GuruFocus
Spine surgery wounds: CellerateRX study finds $3,852 saved per patient - Stock Titan
Sanara MedTech (SMTI) CEO has shares withheld to cover tax on RSU vesting - Stock Titan
(SMTI) Price Dynamics and Execution-Aware Positioning - Stock Traders Daily
Sanara MedTech (SMTI) CEO corrects Form 4 to 414 tax-withheld shares - Stock Titan
Merger Talk: Can Sanara MedTech Inc navigate macro headwindsWeekly Investment Summary & Daily Momentum Trading Reports - baoquankhu1.vn
Valuation Update: Is Sanara MedTech Inc undervalued by DCF analysisRecession Risk & Free Fast Gain Swing Trade Alerts - baoquankhu1.vn
Sanara MedTech Inc. to Report Fourth Quarter and Full Year 2025 Financial Results on March 24, 2026 - marketscreener.com
Sanara MedTech (SMTI) CEO has 491 shares withheld to cover tax on vesting - Stock Titan
Sanara MedTech Unveils 2026 Strategy in Investor Presentation - TipRanks
Sanara Medtech Inc (SMTI) 財務データ
収益
当期純利益
現金流量
EPS
0.95%
0.04%
大文字化:
|
ボリューム (24 時間):